Send us a link
An article on what is needed for personalized medicine to be reality. "Research into how genetic variants can guide successful treatments must become part of routine medical practice and records", says Geoffrey Ginsburg.
At some point we must decide whether we want excellent science or nationally representative science.
Instructors at 259 US institutions were, on average, more likely to respond to fake email requests for mentoring if the senders' names sounded white and male.
By Goodman A, Pepe A, Blocker AW, Borgman CL, Cranmer K, et al. (2014).
Paper challenging the perception of citations as an objective, socially unbiased measure of scientific success.
At the frontiers of scientific discovery, there is a growing problem. Can we still trust our scientists?
Academics have internalised research assessment to such a degree that the effects may be irreversible.
The Open Access Button is seeking £20,000 of funding for Version 2.0 of the tool, which is planned for launch in this October's Open Access Week.
The EU Commission will consider improving Switzerland's status under Horizon 2020, following the announcement by the Swiss government of a plan to facilitate the immigration of Croatian nationals.
At the new Meta-Research Innovation Center at Stanford, or Metrics, John P.A. Ioannidis and Steven N. Goodman, both professors of medicine at Stanford, plan to study how research is done, and how it can be done better.
The Wellcome Trust and the RCUK plan to pilot a streamlined endorsement process to make it easier for outstanding international researchers to obtain Tier 1 Exceptional Talent or Exceptional Promise visas.
A new independent report for CaSE shows that investing public money in science and engineering is good for the economy. [14][two page briefing]
Chief Executive of the ESPRC, has no regrets over the introduction of the council's exercise which prioritises funding according to UK strength and national importance.
Comment on the paper Predicting publication success for biologists.
The NIH is to allow researchers to base new grant applications on ideas that have previously been rejected for funding.
The UK has launched a five-year US$630 million fund to support science and innovation partnerships with researchers in developing countries that will focus on economic development.
What could the UK academic community do with £14.5 million? That is what just 19 Universities in the UK are spending in total during a single year on journal subscriptions to a single publisher.
Report points to 'serious dangers for the international standing of UK research' in humanities and social sciences.
"Today people look at these extraordinary labs and forget that in the 1800s they could still do the exact same science." -- Manu Prakash
Good habits of reproducibility may actually turn out to be a time-saver in the longer run.
Four prominent academics call for an overhaul of the US biomedical research workforce.
Triennial review examining the form, function and governance of the UK’s seven Research Councils.
Bias can taint scientific research, as conclusions are sensitive to the conscious and unconscious choices scientists make in study design, data collection, analysis, and interpretation.
Scientists are asked to comment on static, final, published versions of papers, with virtually no potential to improve the articles. This is the state of post-publication peer review today.
The EU Parliament has adopted a package of public-private and public-public research partnerships worth up to €22bn.
Countries from Finland to Portugal are shaping their higher education policies based on outside rankings, eager for the validation and attention the annual lists bestow, even while they are criticized as flawed or misleading.
Researchers and students are struggling with obstructive rules on immigration to the EU that urgently need updating: scientists from countries outside the EU are not being made welcome and often face problems in moving freely between member states.
The financing of the flagship Human Brain Project is secured through 2016. But what about its future?
Cancer Research UK, AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer
"Die Schweizer Forschung wird künftig international sein oder gar nicht mehr sein."
